Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vizol S Lipid Balance in Moderate to Severe Dry Eye
NCT06323395Phase 3Completed
- Sponsor
- JGL Group
- Start
- Jun 2022
- Primary completion
- Dec 2022
- Modality
- Nanoparticles, Device-based Delivery, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Vizol S Hydro Lipid Balance in dry eye disease (DED), sponsored by JGL Group. Started Jun 2022; status: completed.
02
Drugs
Vizol S Hydro Lipid Balance
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06323395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06323395.